CINPHA (CINPHA) News
Follow CINPHA (CINPHA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Cinclus Pharma to Present at Investing in Life Science on September 22
The 4th edition of Investing in Life Science takes place on September 22 in Stockholm. Christer Ahlberg, CEO will present Cinclus Pharma to specialist life science investors and potential strategic partners.Investing in
EQUITY | Sep 10, 2026, 07:06 AM UTC
L
Cinclus Pharma: Addressing recent concerns around HEEALING1’s statistical power
Redeye’s analyst published a Research Note on Cinclus Pharma.Click here to read the articleMake sure to add Cinclus Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regardi
EQUITY | Sep 04, 2026, 03:01 PM UTC
L
Cinclus Pharma says all Phase III patients completed treatment
Cinclus Pharma reported that all patients have completed treatment in its Phase III study, per a Redeye analyst research note.
EQUITY | Sep 02, 2026, 09:31 AM UTC
M
Cinclus Pharma says last Phase III HEEALING1 patient completes treatment
Cinclus Pharma Holding AB (publ) said the last patient in its Phase III HEEALING1 study completed the treatment period. Topline results are expected in Q4 2026.
EQUITY | Sep 02, 2026, 06:00 AM UTC